Kyntra Bio, Inc. (KYNB)
8.02
+0.02
(+0.25%)
USD |
NASDAQ |
Aug 28, 16:00
7.975
-0.04
(-0.56%)
After-Hours: 20:00
Kyntra Bio Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| December 30, 2022 | 1430.15 |
| December 29, 2022 | 1401.59 |
| December 28, 2022 | 1365.88 |
| December 27, 2022 | 1359.63 |
| December 23, 2022 | 1393.55 |
| December 22, 2022 | 1415.87 |
| December 21, 2022 | 1406.05 |
| December 20, 2022 | 1282.85 |
| December 19, 2022 | 1269.46 |
| December 16, 2022 | 1308.74 |
| December 15, 2022 | 1296.24 |
| December 14, 2022 | 1345.34 |
| December 13, 2022 | 1353.38 |
| December 12, 2022 | 1281.96 |
| December 09, 2022 | 1303.39 |
| December 08, 2022 | 1343.56 |
| December 07, 2022 | 1377.48 |
| December 06, 2022 | 1409.62 |
| December 05, 2022 | 1445.33 |
| December 02, 2022 | 1471.22 |
| December 01, 2022 | 1342.67 |
| November 30, 2022 | 1282.85 |
| November 29, 2022 | 1272.14 |
| November 28, 2022 | 1254.29 |
| November 25, 2022 | 1236.43 |
| Date | Value |
|---|---|
| November 23, 2022 | 1248.04 |
| November 22, 2022 | 1230.18 |
| November 21, 2022 | 1243.57 |
| November 18, 2022 | 1298.03 |
| November 17, 2022 | 1337.31 |
| November 16, 2022 | 1331.95 |
| November 15, 2022 | 1331.95 |
| November 14, 2022 | 1334.63 |
| November 11, 2022 | 1384.62 |
| November 10, 2022 | 1442.65 |
| November 09, 2022 | 1348.92 |
| November 08, 2022 | 1263.21 |
| November 07, 2022 | 1442.65 |
| November 04, 2022 | 1450.69 |
| November 03, 2022 | 1468.54 |
| November 02, 2022 | 1473.01 |
| November 01, 2022 | 1556.03 |
| October 31, 2022 | 1453.36 |
| October 28, 2022 | 1528.35 |
| October 27, 2022 | 1494.43 |
| October 26, 2022 | 1582.81 |
| October 25, 2022 | 1575.67 |
| October 24, 2022 | 1558.71 |
| October 21, 2022 | 1464.08 |
| October 20, 2022 | 1380.16 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Vericel Corp. | 5.663 |
| Capricor Therapeutics, Inc. | 2.263 |
| ARS Pharmaceuticals, Inc. | 46.81 |
| ACADIA Pharmaceuticals, Inc. | 3.835 |
| Alnylam Pharmaceuticals, Inc. | 23.42 |
Price to Book Value Related Metrics
| PE Ratio | 0.2483 |
| PS Ratio | 7.029 |
| Price | 8.02 |
| Earnings Yield | 402.8% |
| Market Cap | 32.47M |
| Normalized PE Ratio | 0.2397 |